BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11192726)

  • 21. Deflavination of cytochrome P450 BM3 by treatment with guanidinium chloride.
    Munro AW; Coggins JR; Lindsay JG; Kelly S; Price NC
    Biochem Soc Trans; 1996 Feb; 24(1):19S. PubMed ID: 8674659
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanistic probes of flavocytochrome P-450 BM3.
    Noble MA; Turner KL; Chapman SK; Munro AW
    Biochem Soc Trans; 1998 Aug; 26(3):S213. PubMed ID: 9765932
    [No Abstract]   [Full Text] [Related]  

  • 23. Probing inter-domain electron transfer in a model flavocytochrome P-450.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S629. PubMed ID: 9450057
    [No Abstract]   [Full Text] [Related]  

  • 24. 4-cyanopyridine, a versatile spectroscopic probe for cytochrome P450 BM3.
    Ost TW; Clark JP; Anderson JL; Yellowlees LJ; Daff S; Chapman SK
    J Biol Chem; 2004 Nov; 279(47):48876-82. PubMed ID: 15364917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox characterisation of flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Daff SN; Turner KL; Chapman SK
    Biochem Soc Trans; 1997 Nov; 25(4):S628. PubMed ID: 9450056
    [No Abstract]   [Full Text] [Related]  

  • 26. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catalytically functional flavocytochrome chimeras of P450 BM3 and nitric oxide synthase.
    Fuziwara S; Sagami I; Rozhkova E; Craig D; Noble MA; Munro AW; Chapman SK; Shimizu T
    J Inorg Biochem; 2002 Sep; 91(4):515-26. PubMed ID: 12237219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching pyridine nucleotide specificity in P450 BM3: mechanistic analysis of the W1046H and W1046A enzymes.
    Neeli R; Roitel O; Scrutton NS; Munro AW
    J Biol Chem; 2005 May; 280(18):17634-44. PubMed ID: 15710617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The interaction of eukaryotic cytochrome b5 with flavocytochrome P-450 BM3 from Bacillus megaterium.
    Munro AW; Noble MA; Turner KL; Chapman SK
    Biochem Soc Trans; 1998 Aug; 26(3):S212. PubMed ID: 9765931
    [No Abstract]   [Full Text] [Related]  

  • 30. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biotransformations using prokaryotic P450 monooxygenases.
    Urlacher V; Schmid RD
    Curr Opin Biotechnol; 2002 Dec; 13(6):557-64. PubMed ID: 12482514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular dynamics simulations of P450 BM3--examination of substrate-induced conformational change.
    Chang YT; Loew GH
    J Biomol Struct Dyn; 1999 Jun; 16(6):1189-203. PubMed ID: 10447203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conformational dynamics in cytochrome P450-substrate interactions.
    Li H; Poulos TL
    Biochimie; 1996; 78(8-9):695-9. PubMed ID: 9010597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of tryptophan 97 of cytochrome P450 BM3 from Bacillus megaterium in catalytic function. Evidence against the 'covalent switching' hypothesis of P-450 electron transfer.
    Munro AW; Malarkey K; McKnight J; Thomson AJ; Kelly SM; Price NC; Lindsay JG; Coggins JR; Miles JS
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):423-8. PubMed ID: 7980400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The catalytic mechanism of cytochrome P450 BM3 involves a 6 A movement of the bound substrate on reduction.
    Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Nat Struct Biol; 1996 May; 3(5):414-7. PubMed ID: 8612070
    [No Abstract]   [Full Text] [Related]  

  • 36. Control of electron transfer in neuronal NO synthase.
    Daff S; Noble MA; Craig DH; Rivers SL; Chapman SK; Munro AW; Fujiwara S; Rozhkova E; Sagami I; Shimizu T
    Biochem Soc Trans; 2001 May; 29(Pt 2):147-52. PubMed ID: 11356143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of alkoxyresorufins as fluorescent substrates for cytochrome P450 BM3 and site-directed mutants.
    Lussenburg BM; Babel LC; Vermeulen NP; Commandeur JN
    Anal Biochem; 2005 Jun; 341(1):148-55. PubMed ID: 15866539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single mutation in cytochrome P450 BM3 changes substrate orientation in a catalytic intermediate and the regiospecificity of hydroxylation.
    Oliver CF; Modi S; Sutcliffe MJ; Primrose WU; Lian LY; Roberts GC
    Biochemistry; 1997 Feb; 36(7):1567-72. PubMed ID: 9048540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
    Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
    Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.